Ingen CEO Live Radio Interview Today With The Money Channel

Increased Sales, Margins and Profits Bring Bright Future for Shareholders

YUCAIPA, Calif., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that the CEO, Scott Sand, discussed increased profits, margins and sales at 11:34am eastern daylight time today on The Money Channel's American Scene Radio with host Steve Crowley.



"The company sales for first quarter had increased more than a 100 times compared to last year due to the acceptance of the product by the home oxygen patients and respiratory medical market. Margins of sales were slightly better than 63%. The future of this company for any investor, compared to other companies in the market place, is strong and steady," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.



The company introduced a new revolutionary product into the medical market this past June-2009, called the Oxyview Nasal Cannula. Oxyview, the World's First Patient In-Line Oxygen Flow-Meter, and Oxyview Nasal Cannula, the World's First Cannula with a built-in oxygen flow meter is another innovative respiratory product manufactured in the USA by Ingen Technologies; providing more confidence and assurance to patients who require home oxygen therapy or supplemental oxygen.


http://www.moneychannel.tv/scas.php

http://www.medcoforum.com/about.php

http://www.chestnet.org/

http://www.copddigest.org/

http://todayssenior.homestead.com/

http://www.mdna.com/shows/medica.html#page=page-1

http://www.arabhealthonline.com/congress/

www.ingen-tech.com


About Ingen: Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009, the company introduced the new Oxyview Nasal Cannula for adult, children and infants. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.


The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472


Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.